These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 11752219
1. Evidence for unique calmodulin-dependent nuclear factor-kappaB regulation in WEHI-231 B cells. Shumway SD, Berchtold CM, Gould MN, Miyamoto S. Mol Pharmacol; 2002 Jan; 61(1):177-85. PubMed ID: 11752219 [Abstract] [Full Text] [Related]
2. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells. Shumway SD, Miyamoto S. Biochem J; 2004 May 15; 380(Pt 1):173-80. PubMed ID: 14763901 [Abstract] [Full Text] [Related]
6. NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis. Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I. J Immunol; 2002 Oct 01; 169(7):3947-53. PubMed ID: 12244195 [Abstract] [Full Text] [Related]
8. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation. Lenert P, Stunz L, YI AK, Krieg AM, Ashman RF. Antisense Nucleic Acid Drug Dev; 2001 Aug 01; 11(4):247-56. PubMed ID: 11572601 [Abstract] [Full Text] [Related]
9. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S, Gelfanov V, Boswell SH, Goulet RJ, Sledge GW, Nakshatri H. Oncogene; 2000 Aug 24; 19(36):4159-69. PubMed ID: 10962577 [Abstract] [Full Text] [Related]
12. Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival. O'Connor S, Shumway S, Miyamoto S. Mol Cancer Res; 2005 Jan 24; 3(1):42-9. PubMed ID: 15671248 [Abstract] [Full Text] [Related]
15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3. Delgado M, Ganea D. J Immunol; 2001 Jan 15; 166(2):1028-40. PubMed ID: 11145682 [Abstract] [Full Text] [Related]
16. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells. Bone H, Williams NA. Int Immunol; 2001 Jun 15; 13(6):807-16. PubMed ID: 11369709 [Abstract] [Full Text] [Related]
17. Lipopolysaccharide-induced NF-kappaB activation in human endothelial cells involves degradation of IkappaBalpha but not IkappaBbeta. Zen K, Karsan A, Eunson T, Yee E, Harlan JM. Exp Cell Res; 1998 Sep 15; 243(2):425-33. PubMed ID: 9743602 [Abstract] [Full Text] [Related]
18. Regulation of NF-kappa B activity by I kappa B alpha and I kappa B beta stability. Krappmann D, Scheidereit C. Immunobiology; 1997 Dec 15; 198(1-3):3-13. PubMed ID: 9442373 [Abstract] [Full Text] [Related]
19. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Ahmad N, Gupta S, Mukhtar H. Arch Biochem Biophys; 2000 Apr 15; 376(2):338-46. PubMed ID: 10775421 [Abstract] [Full Text] [Related]